Reilly Financial Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | $30K | Sell |
407
-48
| -11% | -$3.31K | ﹤0.01% | 493 |
|
|
2021
Q3 | $32K | Hold |
455
| – | – | ﹤0.01% | 446 |
|
|
2021
Q2 | $31K | Hold |
455
| – | – | ﹤0.01% | 460 |
|
|
2021
Q1 | $29K | Sell |
455
-100
| -18% | -$6.45K | ﹤0.01% | 459 |
|
|
2020
Q4 | $32K | Buy |
555
+150
| +37% | +$9.05K | ﹤0.01% | 398 |
|
|
2020
Q3 | $26K | Hold |
405
| – | – | ﹤0.01% | 403 |
|
|
2020
Q2 | $31K | Sell |
405
-220
| -35% | -$16.9K | ﹤0.01% | 379 |
|
|
2020
Q1 | $47K | Hold |
625
| – | – | 0.01% | 306 |
|
|
2019
Q4 | $41K | Sell |
625
-265
| -30% | -$17.3K | ﹤0.01% | 363 |
|
|
2019
Q3 | $56K | Buy |
890
+270
| +44% | +$17.6K | 0.01% | 330 |
|
|
2019
Q2 | $42K | Hold |
620
| – | – | 0.01% | 385 |
|
|
2019
Q1 | $40K | Hold |
620
| – | – | 0.01% | 386 |
|
|
2018
Q4 | $39K | Sell |
620
-800
| -56% | -$55.9K | 0.01% | 372 |
|
|
2018
Q3 | $110K | Buy |
1,420
+704
| +98% | +$53.2K | 0.01% | 234 |
|
|
2018
Q2 | $51K | Hold |
716
| – | – | 0.01% | 310 |
|
|
2018
Q1 | $54K | Sell |
716
-101
| -12% | -$8.03K | 0.01% | 293 |
|
|
2017
Q4 | $58K | Sell |
817
-143
| -15% | -$10.9K | 0.01% | 309 |
|
|
2017
Q3 | $78K | Sell |
960
-254
| -21% | -$19.4K | 0.01% | 250 |
|
|
2017
Q2 | $86K | Sell |
1,214
-570
| -32% | -$37.9K | 0.01% | 232 |
|
|
2017
Q1 | $121K | Sell |
1,784
-1,923
| -52% | -$135K | 0.02% | 183 |
|
|
2016
Q4 | $265K | Sell |
3,707
-118,773
| -97% | -$8.83M | 0.05% | 128 |
|
|
2016
Q3 | $9.69M | Buy |
122,480
+3,901
| +3% | +$317K | 1.72% | 26 |
|
|
2016
Q2 | $9.89M | Buy |
118,579
+15,278
| +15% | +$1.36M | 1.82% | 22 |
|
|
2016
Q1 | $9.49M | Buy |
103,301
+3,168
| +3% | +$286K | 1.62% | 22 |
|
|
2015
Q4 | $10.1M | Buy |
100,133
+6,542
| +7% | +$681K | 1.79% | 17 |
|
|
2015
Q3 | $9.19M | Buy |
93,591
+2,118
| +2% | +$235K | 1.67% | 18 |
|
|
2015
Q2 | $10.7M | Buy |
91,473
+89,623
| +4,844% | +$9.79M | 1.85% | 9 |
|
|
2015
Q1 | $182K | Buy |
1,850
+220
| +13% | +$22.3K | 0.03% | 183 |
|
|
2014
Q4 | $154K | Sell |
1,630
-230
| -12% | -$23.8K | 0.04% | 154 |
|
|
2014
Q3 | $198K | Sell |
1,860
-344
| -16% | -$33.7K | 0.05% | 125 |
|
|
2014
Q2 | $188K | Buy |
2,204
+1,070
| +94% | +$83.3K | 0.04% | 120 |
|
|
2014
Q1 | $80K | Buy |
1,134
+155
| +16% | +$12.2K | 0.02% | 203 |
|
|
2013
Q4 | $74K | Buy |
979
+279
| +40% | +$19.4K | 0.02% | 201 |
|
|
2013
Q3 | $44K | Sell |
700
-424
| -38% | -$25.3K | 0.01% | 241 |
|
|
2013
Q2 | $59K | Buy |
+1,124
| New | +$58.6K | 0.02% | 191 |
|
Other funds holding GILD
Reilly Financial Advisors's GILD Position: Q4 2021 in Review
Reilly Financial Advisors reduced its Gilead Sciences (GILD) stake by 11% in Q4 2021, selling an estimated $3.31K and leaving 407 shares worth $30K. The position accounts for ﹤0.01% of the portfolio, ranked #493.
Reilly Financial Advisors first reported a position in GILD in Q2 2013 and has held it in 35 quarters since. The position peaked at $10.7M in Q2 2015. 1,683 funds tracked by Wall St. Rank hold GILD as of Q4 2021.
- Reilly Financial Advisors held 407 shares of Gilead Sciences worth $30K as of Q4 2021.
- Reilly Financial Advisors sold 48 Gilead Sciences shares in Q4 2021, an estimated $3.31K.
- Gilead Sciences made up ﹤0.01% of Reilly Financial Advisors's portfolio in Q4 2021, its #493 holding.
- Reilly Financial Advisors first reported a position in Gilead Sciences in Q2 2013 and has held it in 35 quarters since.
- Reilly Financial Advisors's Gilead Sciences position peaked at $10.7M in Q2 2015.
- 1,683 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2021.
Based on Reilly Financial Advisors's 13F filing for Q4 2021, filed 25 Jan 2022.